← Back to headlines





FDA Expedites Review of Psychedelic Drugs for Mental Health Treatment
The FDA has announced new steps to speed up research and review of psychedelic treatments for serious mental health conditions, with initial approvals potentially coming as early as summer, following an executive order.
25 Apr, 00:30 — 25 Apr, 00:30
Related Stories

'Astronauts back on Earth': Artemis II crew splashes down after record-breaking moon flyby – video
just now

WHO Approves First Malaria Treatment for Newborns
24m ago

Scientists Revive 24,000-Year-Old 'Zombie Worm' from Arctic Permafrost
1h ago

Expert Advocates for Scientific Approach to Air Pollution
1h ago